About

Publications While At HealthPartners

selected publications

Journal Article

Validation of immunotherapy response score as predictive of pan-solid tumor anti-PD-1/PD-L1 benefit. 

Cancer Res Commun. 2023

Randomized phase II trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: results of PrE0102. 

Journal of Clinical Oncology. 2018

Contact

full name

T. R. Wassenaar

Quick Info

 

Collaboration

Co-author network

Map of science